Prescription Drug Transparency and Affordability Act
Official title: To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1984 to increase oversight of pha… Show full official titleShow less
Official title: To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1984 to increase oversight of pharmacy benefit management services, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Prescription Drug Transparency and Affordability Act
This bill requires pharmacy benefit managers (PBMs) to report, at least once every six months, prescription drug pricing, payment, and utilization data to the health insurance plans for which the PBM provides services.
Specifically, a PBM contracted to provide services to an employer or sponsor offering a large group health insurance plan (i.e., a plan with at least 100 employees or participants) must report to the plan certain information for prescription drug claims under the plan. This includes, for each drug, the difference between the compensation paid by the plan to the PBM and the compensation paid by the PBM to the pharmacy.
Further, for each therapeutic class of drugs under the plan, a PBM must report (1) the total amount it received in rebates, fees, and discounts; and (2) the net spending for each class after such rebates, fees, and discounts.
Each PBM also must report certain information about (1) drugs for which total spending exceeded $10,000; and (2) drugs dispensed through pharmacies affiliated with the plan or PBM, such as the percentage of prescriptions dispensed by such affiliates.
Finally, a PBM providing services to any group health insurance plan must provide the plan with a summary document that includes similar information for prescription drug claims under the plan, as determined by the Department of Health and Human Services. Plans must also make certain aggregate summary information available to plan participants.
PBMs and plans that violate these requirements are subject to civil penalties.
- Introduced in House Formatted Text PDF Formatted XML
- SOCIETY FOR HUMAN RESOURCE MANAGEMENT
- BOEING COMPANY
- AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
- ELEVANCE HEALTH, INC.
- NATIONAL DOWN SYNDROME CONGRESS
- NISKANEN CENTER FOR PUBLIC POLICY
Bodies those filers lobbied
- HOUSE OF REPRESENTATIVES
- SENATE
- Health & Human Services, Dept of (HHS)
- Centers For Medicare and Medicaid Services (CMS)
- White House Office
- Labor, Dept of (DOL)
- Executive Office of the President (EOP)
- Commerce, Dept of (DOC)
Cite this page
U.S. Congress. (2026). H.R. 2450: Prescription Drug Transparency and Affordability Act. 119th Congress. Open America. https://openamerica.io/bill/119-HR-2450/
"H.R. 2450: Prescription Drug Transparency and Affordability Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-2450/.
H.R. 2450, 119th Cong. (2026), https://openamerica.io/bill/119-HR-2450/.
[H.R. 2450: Prescription Drug Transparency and Affordability Act](https://openamerica.io/bill/119-HR-2450/)